Prader-Willi Syndrome clinical trials at UC Irvine
3 in progress, 1 open to eligible people
Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome
open to eligible people ages 5-30
12-week, randomized, double-blind, placebo-controlled, parallel-group study of carbetocin nasal spray for the treatment of hyperphagia in Prader-Willi syndrome (PWS)
Orange, California and other locations
OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome
Sorry, accepting new patients by invitation only
To evaluate long-term safety and tolerability of carbetocin nasal spray (3.2 mg TID) in subjects with PWS
Orange, California and other locations
DCCR in Patients With Prader-Willi Syndrome
Sorry, in progress, not accepting new patients
The purpose of this is study is to evaluate the long-term safety of DCCR (diazoxide choline) extended-release tablets) in patients with Prader-Willi syndrome.
Orange, California and other locations
Last updated: